Severance Hospital
Seoul, 120-752, South Korea
NCT Number: NCT01308320
Fentanyl is expected to suppress tracheal tube-induced cough during emergence from general anaesthesia through binding to its receptors in the brainstem. However, it has not been proven if fentanyl has a complication-free, dose-dependent effect on cough suppression during emergence from sevoflurane anaesthesia. The purpose of this study is to evaluate the relationship between fentanyl doses and cough suppression during emergence from sevoflurane anaesthesia.
Looking for future studies?
Notify Me20 year–59 year
Female
Interventional
Phase 4
Seoul, 120-752, South Korea
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
According to the enrolled group, certain dose of fentanyl is intravenously administered by bolus just after sevoflurane discontinuation.
According to the enrolled group, certain dose of saline is intravenously administered by bolus just after sevoflurane discontinuation.
Yonsei University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03037385
Adenocarcinoma, Adenocarcinoma, Papillary
Phoenix, Arizona, United States
View Trial DetailsNCT04574947
Anesthesia, Endocrine Gland Neoplasms
Saint Petersburg, Russia
View Trial DetailsNCT03012620
Adenocarcinoma, Adnexal Diseases
Villejuif, France
View Trial DetailsNCT06275425
Cough, Endocrine Gland Neoplasms
Seoul, South Korea
View Trial Details